Modeled Health and Economic Impact of Team-Based Care for Hypertension

Steven P. Dehmer, Madeleine M. Baker-Goering, Michael V. Maciosek, Yuling Hong, Thomas E. Kottke, Karen L. Margolis, Julie C. Will, Thomas J. Flottemesch, Amy B. Lafrance, Brian C. Martinson, Avis J. Thomas, Kakoli Roy

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Introduction Team-based interventions for hypertension care have been widely studied and shown effective in improving hypertension outcomes. Few studies have evaluated long-term effects of these interventions; none have assessed broad-scale implementation. This study estimates the prospective health, economic, and budgetary impact of universal adoption of a team-based care intervention model that targets people with treated but uncontrolled hypertension in the U.S. Methods Analysis was conducted in 2014-2015 using a microsimulation model, constructed with various data sources from 1948 to 2014, designed to evaluate prospective cardiovascular disease (CVD)-related interventions in the U.S. population. Ten-year primary outcomes included prevalence of uncontrolled hypertension; incident myocardial infarction, stroke, CVD events, and CVD-related mortality; intervention and net medical costs by payer; productivity; and quality-adjusted life years. Results About 4.7 million (13%) fewer people with uncontrolled hypertension and 638,000 prevented cardiovascular events would be expected over 10 years. Assuming $525 per enrollee, implementation would cost payers $22.9 billion, but $25.3 billion would be saved in averted medical costs. Estimated net cost savings for Medicare approached $5.8 billion. Net costs were especially sensitive to intervention costs, with break-even thresholds of $300 (private), $450 (Medicaid), and $750 (Medicare). Conclusions Nationwide adoption of team-based care for uncontrolled hypertension could have sizable effects in reducing CVD burden. Based on the study's assumptions, the policy would be cost saving from the perspective of Medicare and may prove to be cost effective from other payers' perspectives. Expected net cost savings for Medicare would more than offset expected net costs for all other insurers.

Original languageEnglish (US)
Pages (from-to)S34-S44
JournalAmerican journal of preventive medicine
Volume50
Issue number5
DOIs
StatePublished - May 1 2016

Bibliographical note

Funding Information:
The authors wish to acknowledge Zhuo Yang, in the Office of the Associate Director for Policy at CDC, for his data assistance and Anil Thota, formerly in the Community Guide Branch at CDC, for his subject matter expertise. Support for this study was provided under contract 200-2012-53738 with CDC.

Fingerprint Dive into the research topics of 'Modeled Health and Economic Impact of Team-Based Care for Hypertension'. Together they form a unique fingerprint.

Cite this